Tim H Brümmendorf

Targeting of BCR-ABL1 and IRE1α induces synthetic lethality in Philadelphia-positive acute lymphoblastic leukemia.

C. Preisinger, Afshin Samali, J. Patterson, 2020, Carcinogenesis.